1.Effects of Jieyu-Chufan capsule on the behavior and the level of cerebral monoamine ;neurotransmitter in depression mouse model
Yuqing TAN ; Chunhua GU ; Qing YANG ; Long QIN ; Lanfang LI
International Journal of Traditional Chinese Medicine 2016;38(10):914-917
Objective To observe the effects of Jieyu-Chufan capsule(JCC) on the behavior and the monoamine neurotransmitter content of cerebral in depression mouse model and explore its mechanism. Methods The ICR male mouse were randomly divided into seven groups according to their weights(the model group, the low, middle and high doses group, Baiyoujie group, the amitriptyline group, the normal control group). The low, middle and high doses group were given JCC with 1.250, 2.500, 5.000 g/kg separately by intragastric administration. Baiyoujie group was given 0.014 g/kg Baiyoujie by gavage. The amitriptyline group was given 0.050 g/kg amitriptyline by gavage. The model group and the normal control group received the same volume of distilled water intragastrically. The drugs were administrated once a day. The brepharoptosis and movement conditions of mouse were observed after 22 days. The monoamine neurotransmitter content of each group was measured after 25 days. Results Compared to the model group, the number of mouse with brepharoptosis decreased in the high dose group after 1, 2, 6 hour with reserpine injection (P<0.05 or P<0.01);the number of mouse came out from the circle increased after 4 hours with reserpine injection (P<0.05 or P<0.01);the content of NA (880.45 ± 428.81 ng/g, 875.98 ± 449.33 ng/g vs. 299.92 ± 267.08 ng/g) and DA (2 305.99 ± 530.37 ng/g, 2 169.99 ± 278.19 ng/g vs. 1 439.34 ± 357.33 ng/g) in the middle and high dose group increased (P<0.01);the content of 5-HT (781.43 ± 135.10 ng/g vs. 492.01 ± 192.80 ng/g) in the middle group increased (P<0.01). Conclusions JCC showed an antidepression influence in depression mouse model induced by reserpine. The mechanism may be related to regulating the level of monoamine neurotransmitter in the nervous centralis .
2.In vitro regulatory effects of IL-18 on natural killer-like B cells in patients with primary hepatocellular carcinoma
Lanfang ZHANG ; Daiyuan DONG ; Lu YANG ; Jun KUAI ; Fang YANG ; Yongmei QIN
Chinese Journal of Microbiology and Immunology 2021;41(11):836-842
Objective:To investigate the changes in peripheral blood and liver-infiltrating natural killer-like B (NKB) cells in patients with primary hepatocellular carcinoma (HCC), and to assess the influence of IL-18 on NKB cells in vitro and the underlying mechanism. Methods:Forty-three HCC patients and 21 normal controls (NC) were enrolled in the study. Peripheral blood samples were collected to isolate plasma and peripheral blood mononuclear cells (PBMC). Intrahepatic lymphocytes (IHL) were isolated from tumor tissues and para-tumor tissues obtained from 16 HCC patients who received surgery. IL-12, IL-18 and IL-18 binding protein (IL-18BP) levels in plasma were measured by enzyme linked immunosorbent assay. The percentages of CD3 -NKp46 + CD19 + NKB cells and IL-18 + NKB cells in PBMC and IHL were analyzed by flow cytometry. Changes in the percentages of NKB cells and IL-18 + NKB cells were measured after stimulating PBMC and IHL with recombinant human IL-18 (1 ng/ml and 10 ng/ml). Changes in IL-18BP levels in the culture supernatants and phosphorylated nuclear factor-κB (NF-κB) in NKB cells were also assessed. Student′s t test, one-way analysis of variance or LSD-t test was used for statistical analysis. Results:There was no significant difference in plasma IL-12 level between HCC patients and NC ( P=0.245). Compared with NC, HCC patients had decreased IL-18 level in plasma [(224.3±58.89) pg/ml vs (327.0±52.27) pg/ml, P<0.000 1], but increased IL-18BP level [(4.421±0.97) ng/ml vs (0.92±0.18) ng/ml, P<0.000 1]. The percentages of peripheral blood NKB cells and IL-18 + NKB cells were lower in HCC patients than in NC [(2.68±1.23)% vs (8.88±2.95)% and (54.42±12.60)% vs (69.74±12.65)%, both P<0.000 1]. The percentage of NKB cells in IHL was reduced in tumor tissues as compared with that in para-tumor tissues [(2.89±0.86)% vs (4.66±1.17)%, P<0.000 1]. Moreover, the percentage of IL-18 + NKB cell was also down-regulated in tumor tissues as compared with that in para-tumor tissues [(51.50±13.18)% vs (62.13±9.24)%, P=0.013]. Recombinant human IL-18 stimulation reduced the IL-18BP level in the culture supernatants ( P<0.05). IL-18 stimulation at 1 ng/ml did not affect NKB cell percentage, IL-18 + NKB cell percentage or NF-κB phosphorylation in NKB cells from PBMC or IHL ( P>0.05), while 10 ng/ml of IL-18 not only elevated NKB cell percentage and IL-18+ NKB cell percentage, but also promoted NF-κB phosphorylation in NKB cells ( P<0.01). Conclusions:In vitro stimulation with high concentration of IL-18 might promote NF-κB phosphorylation by inhibition of IL-18BP expression. This process might play a positive feedback role to induce the activation of NKB cells and IL-18 secretion.
3.Values of serum tumor necrosis factor-α stimulated gene 6 protein and type ⅩⅥ collagen in predicting prognosis of patients with ulcerative colitis
Lijun MENG ; Lanfang ZHANG ; Lei QIN ; Wenjing LI ; Peijun SHEN ; Xu CHEN ; Xiaohe GUO
Journal of Clinical Medicine in Practice 2024;28(23):87-90
Objective To analyze the values of serum tumor necrosis factor-α stimulated gene 6 protein (TSG-6) and type ⅩⅥ collagen (col-16) in predicting the prognosis of patients with ulcerative colitis (UC). Methods A total of 160 patients with UC were enrolled as UC group, another 160 volunteers were selected as control group, and the levels of serum TSG-6 and col-16 were compared between the two groups. According to the modified Mayo scoring criteria, patients in the UC group were divided into mild group (
4.Case report of Langerhans cell histiocytosis in 2 neonates
Lu QIN ; Feizhou ZHANG ; Tongyu YANG ; Wanli FENG ; Lanfang TANG
Chinese Journal of Applied Clinical Pediatrics 2021;36(21):1659-1661
To analyze the clinical data of 2 neonates with Langerhans cell histiocytosis (LCH). The rashes appeared in both cases shortly after birth.Case 1 had both rashes and neonatal sepsis, and no other tissues and organs were involved.After anti-infective treatment, the rashes gradually disappeared.Case 2 had secondary pneumonia, abnormal coagulation function and gastrointestinal bleeding.Both cases were positive for CD1a and S-100 by immunohistochemical staining of skin biopsy, and they were diagnosed as multi system-LCH.The early diagnosis of LCH is particularly important.The detection methods of skin or lymph node biopsy like immunohistochemistry, need to be performed as early as possible.Because the course of the disease is not clear, a close monitoring and follow-up are needed.
5.Visual analysis of application of clinical decision support system in nursing field
Lanfang QIN ; Yi ZHU ; Pingping CHEN
China Modern Doctor 2023;61(34):81-86
Objective To analyze the current status of application of clinical decision support system(CDSS)in nursing field,and to provide reference for related research in China.Methods Literature on CDSS in nursing published in the Web of Science core database from January 1,2009 to April 10,2022 was searched.CiteSpace and VOSviewer software were used for visual analysis of journals,countries,key words,etc.Results A total of 2030 literatures were included,and the overall number of publications and citations showed an upward trend.PLoS One was the journal with the highest number of publications,the United States had the highest number of publications,strategies,challenges and burdens were the key words that appeared in recent years.The field had changed from exploratory clinical research to clinical practice,and the challenges and burdens encountered by CDSS in clinical practice and the countermeasures were the current research hotspots.Conclusion Currently,the application of CDSS in clinical care is in its infancy and still faces many challenges,and there is an urgent need for more high-quality research to improve the quality of clinical care and the efficiency of nurses,and to reduce the burden of work.
6.Effect of tegafur,gimeracil and oteracil potassium combined with oxaliplatin on gastric motility-related hormones,matrix metalloproteinase-2 and matrix metalloproteinase-9 in elderly patients with gastric cancer
Lanfang ZHANG ; Xu CHEN ; Jun KUAI ; Lei QIN ; Yan YANG ; Tingmin CHANG
Journal of Clinical Medicine in Practice 2024;28(12):57-60,65
Objective To investigate the effects of tegafur,gimeracil and oteracil potassium combined with oxaliplatin on gastric motility-related hormones,matrix metalloproteinase-2(MMP-2)and matrix metalloproteinase-9(MMP-9)in elderly patients with gastric cancer.Methods A total of 128 elderly patients with gastric cancer were selected as the study subjects and randomly divided into control group(n=64)and observation group(n=64).The control group was treated with tegafur,gimeracil and oteracil potassium,while the observation group received tegafur,gimeracil and oteracil potassium combined with oxaliplatin.Gastric motility-related hormones[motilin(MTL)and vasoac-tive intestinal peptide(VIP)],MMP-2,MMP-9,tumor markers[carcinoembryonic antigen(CEA),carbohydrate antigen 125(CA125)and carbohydrate antigen 19-9(CA19-9)],clinical ef-ficacy and occurrence of adverse reactions were observed in both groups.The correlations of gastric motility-related hormones with the levels of MMP-2,MMP-9 and tumor markers were analyzed.Re-sults After treatment,MTL levels in both groups were significantly lower,while VIP levels were signifi-cantly higher compared to before treatment.Additionally,the observation group had significantly lower MTL and higher VIP levels compared to the control group(P<0.05).After treatment,the levels of MMP-2,MMP-9,CEA,CA125 and CA19-9 were significantly reduced in both groups compared to pretreatment levels,with the observation group showing significantly lower levels than the control group(P<0.05).The total effective rate in the observation group was 70.31%,which was signifi-cantly higher than the 53.13%in the control group(P<0.05).There was no statistically signifi-cant difference in the incidence of adverse reactions between the two groups(P>0.05).A negative correlation was observed between MTL and MMP-2,MMP-9,CEA,CA125 as well as CA19-9(P<0.05),while VIP showed a positive correlation with MMP-2,MMP-9,CEA,CA125 and CA19-9(P<0.05).Conclusion The combination of tegafur,gimeracil and oteracil potassium and oxali-platin is effective and safe for the treatment of elderly patients with gastric cancer.MTL,VIP,MMP-2,MMP-9,CEA,CA125 and CA19-9 are interrelated in the development of gastric cancer in elderly patients.
7.Effect of tegafur,gimeracil and oteracil potassium combined with oxaliplatin on gastric motility-related hormones,matrix metalloproteinase-2 and matrix metalloproteinase-9 in elderly patients with gastric cancer
Lanfang ZHANG ; Xu CHEN ; Jun KUAI ; Lei QIN ; Yan YANG ; Tingmin CHANG
Journal of Clinical Medicine in Practice 2024;28(12):57-60,65
Objective To investigate the effects of tegafur,gimeracil and oteracil potassium combined with oxaliplatin on gastric motility-related hormones,matrix metalloproteinase-2(MMP-2)and matrix metalloproteinase-9(MMP-9)in elderly patients with gastric cancer.Methods A total of 128 elderly patients with gastric cancer were selected as the study subjects and randomly divided into control group(n=64)and observation group(n=64).The control group was treated with tegafur,gimeracil and oteracil potassium,while the observation group received tegafur,gimeracil and oteracil potassium combined with oxaliplatin.Gastric motility-related hormones[motilin(MTL)and vasoac-tive intestinal peptide(VIP)],MMP-2,MMP-9,tumor markers[carcinoembryonic antigen(CEA),carbohydrate antigen 125(CA125)and carbohydrate antigen 19-9(CA19-9)],clinical ef-ficacy and occurrence of adverse reactions were observed in both groups.The correlations of gastric motility-related hormones with the levels of MMP-2,MMP-9 and tumor markers were analyzed.Re-sults After treatment,MTL levels in both groups were significantly lower,while VIP levels were signifi-cantly higher compared to before treatment.Additionally,the observation group had significantly lower MTL and higher VIP levels compared to the control group(P<0.05).After treatment,the levels of MMP-2,MMP-9,CEA,CA125 and CA19-9 were significantly reduced in both groups compared to pretreatment levels,with the observation group showing significantly lower levels than the control group(P<0.05).The total effective rate in the observation group was 70.31%,which was signifi-cantly higher than the 53.13%in the control group(P<0.05).There was no statistically signifi-cant difference in the incidence of adverse reactions between the two groups(P>0.05).A negative correlation was observed between MTL and MMP-2,MMP-9,CEA,CA125 as well as CA19-9(P<0.05),while VIP showed a positive correlation with MMP-2,MMP-9,CEA,CA125 and CA19-9(P<0.05).Conclusion The combination of tegafur,gimeracil and oteracil potassium and oxali-platin is effective and safe for the treatment of elderly patients with gastric cancer.MTL,VIP,MMP-2,MMP-9,CEA,CA125 and CA19-9 are interrelated in the development of gastric cancer in elderly patients.
8.HPCAL1 is a novel driver of autophagy-dependent ferroptosis.
Liwen WANG ; Qin LI ; Huimei LIU ; Lanfang LI
Journal of Zhejiang University. Science. B 2023;24(11):1053-1056
自噬是细胞内一种高度保守的生理过程,可通过溶酶体系统降解过量或受损的细胞器、有毒的蛋白聚集体和病原体等。最新研究表明,海马钙素样1(HPCAL1)可作为特异性自噬受体和铁死亡的正调节因子。HPCAL1可选择性降解钙粘素2(CDH2),加速脂质过氧化,促进癌细胞铁死亡。iHPCAL1是抑制HPCAL1的小分子化合物,可抑制Erastin诱导的肿瘤细胞铁死亡。此外,它还可以抑制铁死亡诱导的急性胰腺炎。本文通过对HPCAL1在铁死亡中的具体作用机制进行概述,为HPCAL1作为铁死亡相关疾病的潜在治疗靶点提供新思路和理论依据。
Ferroptosis
;
Cell Line, Tumor
;
Autophagy
9.Governer Vessel (督脉) Moxibustion for Regulating and Replenishing Spleen and Kidney Yang Deficiency in Patients with Amyotrophic Lateral Sclerosis:22 Cases Observation
Hui XU ; Lanfang QIN ; Tao QIU ; Chao QIU
Journal of Traditional Chinese Medicine 2024;65(17):1802-1807
ObjectiveTo observe the clinical effect and safety of Governer Vessel (督脉) moxibustion on amyotrophic lateral sclerosis (ALS) patients with spleen and kidney yang deficiency. MethodsForty-four ALS patients with spleen and kidney yang deficiency were finally enrolled, and they were divided into 22 cases each in the treatment group and the control group. The control group was treated with oral riluzole tablets, intravenous drip of edaravone injection, oral Qiu's Wenshen Zhiwei Decoction (裘氏温肾止痿汤), and conventional rehabilitation nursing, while the treatment group was additionally given Governer Vessel moxibustion based on the control group. The moxibustion treatment was applied once a week for a course of 2 weeks. Both groups were treated for 3 months. The scores of amyotrophic lateral sclerosis symptom score in integrative treatments (ALS-SSIT) for evaluating therapeutic effect of traditional Chinese medicine and amyotrophic lateral sclerosis functional rating scale-revised (ALSFRS-R) were assessed before treatment and after 1 month, 2 months and 3 months treatment, and the occurrence of adverse reactions in both groups was observed. ResultsThe treatment group showed a significant decrease in oropharyngeal function score, muscle function score, and non-motor symptom score, and an increase in ALSFRS-R scale scores after 1, 2, and 3 months of treatment (P<0.05). The scores of oropharyngeal function and muscle function in the control group increased, while the ALSFRS-R score decreased after 1, 2 and 3 months of treatment, and the non-motor symptom score decreased after 2 and 3 months of treatment (P<0.05). The scores of muscle function and non-motor symptoms in the treatment group were lower than those in the control group after 1 month of treatment; the scores of oropharyngeal function, muscle function and non-motor symptoms were lower than those in the control group, while the ALSFRS-R score was higher after 2 months and 3 months of treatment (P<0.05). Constipation (3 cases), skin itching (2 cases), skin rash (1 case), and dry mouth and tongue (1 case) occurred in the treatment group, while there were 2, 1, 2, and 2 cases of each adverse reaction in the control group, respectively, with no significant difference in the incidence of adverse reactions between the two groups (P>0.05). ConclusionDu mai moxibustion on the basis of integrated Chinese and western medication and conventional rehabilitation care can help improve some clinical symptoms of ALS patients with spleen-kidney yang deficiency, and has good safety.